Acquired by Bruker Corporation in Dec 2024
NSTG - NanoString Technologies, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Seattle,
United States
Type: Equity
NSTG price evolution
NSTG
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $94.1 | $114.93 | $122.03 | $113.15 |
| Short term investments | $3.3 | $3.3 | $33.24 | $84.28 |
| Net receivables | $48.35 | $42.98 | $34.87 | $31.51 |
| Inventory | $55.16 | $48.85 | $46.71 | $43.27 |
| Total current assets | $211.81 | $221.44 | $251.86 | $286.77 |
| Long term investments | ||||
| Property, plant & equipment | $59.41 | $63.4 | $64.21 | $62.04 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $62.91 | $67.55 | $68.56 | $66.64 |
| Total investments | $3.3 | $3.3 | $33.24 | $84.28 |
| Total assets | $274.71 | $288.99 | $320.42 | $353.41 |
| Current liabilities | ||||
| Accounts payable | $33.34 | $20.87 | $20.49 | $16.62 |
| Deferred revenue | $18.47 | $17.12 | $16.25 | $13.34 |
| Short long term debt | $5.58 | $5.44 | $5.33 | $5.52 |
| Total current liabilities | $77.53 | $62.43 | $57.99 | $58.86 |
| Long term debt | $242.12 | $243.18 | $244.2 | $226.62 |
| Total noncurrent liabilities | $247.75 | $248.02 | $248.8 | $248.74 |
| Total debt | $247.7 | $248.62 | $249.54 | $250.5 |
| Total liabilities | $325.28 | $310.45 | $306.8 | $307.6 |
| Shareholders' equity | ||||
| Retained earnings | -$931.61 | -$894.2 | -$850.53 | -$809.3 |
| Other shareholder equity | $0 | $0 | -$0.06 | -$0.59 |
| Total shareholder equity | -$50.57 | -$21.46 | $13.62 | $45.81 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $113.15 | $107.07 | $411.85 | $29.03 |
| Short term investments | $84.28 | $241.82 | $28.88 | $127.82 |
| Net receivables | $31.51 | $40.13 | $31.1 | $27.15 |
| Inventory | $43.27 | $31.49 | $22.96 | $19.78 |
| Total current assets | $286.77 | $427.62 | $498.98 | $212.61 |
| Long term investments | ||||
| Property, plant & equipment | $62.04 | $46.27 | $42.32 | $44.83 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $66.64 | $51.86 | $45.22 | $47.15 |
| Total investments | $84.28 | $241.82 | $28.88 | $127.82 |
| Total assets | $353.41 | $479.48 | $544.2 | $259.75 |
| Current liabilities | ||||
| Accounts payable | $16.62 | $14.28 | $5.31 | $10.28 |
| Deferred revenue | $13.34 | $11 | $7.45 | $4.97 |
| Short long term debt | $5.52 | $4.89 | $4.31 | $3.77 |
| Total current liabilities | $58.86 | $52.16 | $37.1 | $44.99 |
| Long term debt | $226.62 | $246.84 | $198.31 | $109.32 |
| Total noncurrent liabilities | $248.74 | $250.36 | $200.15 | $110.62 |
| Total debt | $250.5 | $251.73 | $202.62 | $113.08 |
| Total liabilities | $307.6 | $302.52 | $237.25 | $155.6 |
| Shareholders' equity | ||||
| Retained earnings | -$809.3 | -$649.75 | -$542.03 | -$431.95 |
| Other shareholder equity | -$0.59 | -$0.32 | $0.08 | $0.14 |
| Total shareholder equity | $45.81 | $176.96 | $306.95 | $104.15 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $48.09 | $44.16 | $35.8 | $34.42 |
| Cost of revenue | $30.69 | $29.76 | $22.87 | $21.12 |
| Gross Profit | $17.4 | $14.4 | $12.93 | $13.3 |
| Operating activities | ||||
| Research & development | $17.11 | $18.21 | $16.12 | $19.09 |
| Selling, general & administrative | $36.76 | $39.08 | $37.37 | $36.9 |
| Total operating expenses | $53.87 | $57.29 | $53.48 | $55.98 |
| Operating income | -$36.47 | -$42.89 | -$40.55 | -$42.68 |
| Income from continuing operations | ||||
| EBIT | -$35.56 | -$41.57 | -$39.27 | -$42.23 |
| Income tax expense | -$0.05 | $0.2 | $0.07 | -$0.01 |
| Interest expense | $1.9 | $1.89 | $1.89 | $1.89 |
| Net income | ||||
| Net income | -$37.41 | -$43.67 | -$41.24 | -$44.11 |
| Income (for common shares) | -$37.41 | -$43.67 | -$41.24 | -$44.11 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $127.26 | $145.09 | $117.32 | $125.57 |
| Cost of revenue | $65.47 | $68.3 | $52.41 | $44.04 |
| Gross Profit | $61.79 | $76.78 | $64.91 | $81.53 |
| Operating activities | ||||
| Research & development | $70.84 | $69.5 | $62.86 | $68.03 |
| Selling, general & administrative | $143.13 | $115.5 | $90.1 | $96.19 |
| Total operating expenses | $213.97 | $185.01 | $152.95 | $164.23 |
| Operating income | -$152.18 | -$108.23 | -$88.05 | -$82.7 |
| Income from continuing operations | ||||
| EBIT | -$151.69 | -$107.6 | -$94.42 | -$31.94 |
| Income tax expense | $0.32 | $0.17 | $0.25 | $0.27 |
| Interest expense | $7.54 | $7.49 | $15.41 | $8.49 |
| Net income | ||||
| Net income | -$159.54 | -$115.25 | -$110.08 | -$40.7 |
| Income (for common shares) | -$159.54 | -$115.25 | -$110.08 | -$40.7 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$37.41 | -$43.67 | -$41.24 | -$44.11 |
| Operating activities | ||||
| Depreciation | $5.07 | $5.01 | $4.64 | $4.04 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.44 | $8.44 | $7.63 | $6.26 |
| Total cash flows from operations | -$19.7 | -$31.45 | -$35.75 | -$28.08 |
| Investing activities | ||||
| Capital expenditures | -$1.92 | -$5.69 | -$7.68 | -$5.48 |
| Investments | $30 | $51.48 | $29.59 | |
| Total cash flows from investing | -$1.92 | $24.31 | $43.8 | $24.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.87 | $0.09 | $1.37 | $0.02 |
| Net borrowings | -$0.04 | -$0.06 | -$0.07 | -$0.08 |
| Total cash flows from financing | $0.82 | $0.04 | $0.81 | -$0.05 |
| Effect of exchange rate | -$0.04 | $0 | $0.02 | $0.1 |
| Change in cash and equivalents | -$20.83 | -$7.1 | $8.88 | -$3.92 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$159.54 | -$115.25 | -$110.08 | -$40.7 |
| Operating activities | ||||
| Depreciation | $12.21 | $9.32 | $8.98 | $7.75 |
| Business acquisitions & disposals | $40 | |||
| Stock-based compensation | $25.91 | $30.17 | $19.37 | $17.46 |
| Total cash flows from operations | -$128.61 | -$90.55 | -$81.66 | -$89.42 |
| Investing activities | ||||
| Capital expenditures | -$23.07 | -$8.65 | -$7.46 | -$7.88 |
| Investments | $155.56 | -$211.57 | $98.7 | -$47.27 |
| Total cash flows from investing | $132.5 | -$220.22 | $91.24 | -$15.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.11 | $8.88 | $237.44 | $90.84 |
| Net borrowings | -$0.33 | -$0.24 | $145.02 | $20 |
| Total cash flows from financing | $2.27 | $6.06 | $373.05 | $109.27 |
| Effect of exchange rate | -$0.08 | -$0.07 | $0.19 | -$0.01 |
| Change in cash and equivalents | $6.08 | -$304.78 | $382.63 | $4.69 |
News
Fundamentals
| Market cap | $5.07M |
|---|---|
| Enterprise value | $158.67M |
| Shares outstanding | 48.11M |
| Revenue | $162.47M |
|---|---|
| EBITDA | -$139.88M |
| EBIT | -$158.64M |
| Net Income | -$166.43M |
| Revenue Q/Q | 62.79% |
| Revenue Y/Y | 20.09% |
| P/E ratio | -0.03 |
|---|---|
| EV/Sales | 0.98 |
| EV/EBITDA | -1.13 |
| EV/EBIT | -1.00 |
| P/S ratio | 0.03 |
| P/B ratio | -0.10 |
| Book/Share | -1.05 |
| Cash/Share | 1.96 |
| EPS | -$3.46 |
|---|---|
| ROA | -53.79% |
| ROE | 5.29K% |
| Debt/Equity | 6.71 |
|---|---|
| Net debt/EBITDA | -1.65 |
| Current ratio | 2.73 |
| Quick ratio | 2.02 |